Detection of CBFβ/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation

Bone Marrow Transplantation

Volumn 21, Issue 2, 1998, Pages 159-166

  Elmaagacli, A H ^a   Beelen, D W ^a   Kroll, M ^a   Trzensky, S ^a   Stein, C ^a   Schaefer, U W ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

AML; BMT; CBF MYH11; Inv(16); MRD

Indexed keywords

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; ALLOGENIC BONE MARROW TRANSPLANTATION; ARTICLE; AUTOTRANSPLANTATION; BLOOD; BONE MARROW; CEREBROSPINAL FLUID; CHIMERA; CLINICAL ARTICLE; DIAGNOSTIC VALUE; FEMALE; GENE FUSION; GENETIC TRANSCRIPTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MALE; MINIMAL RESIDUAL DISEASE; PATIENT MONITORING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL; ALLOTRANSPLANTATION; BONE MARROW TRANSPLANTATION; CHROMOSOME 16; CHROMOSOME INVERSION; GENETICS; NUCLEOTIDE SEQUENCE; SENSITIVITY AND SPECIFICITY; STATISTICS; TIME;

CBFBETA MYH11 FUSION PROTEIN; CBFBETA-MYH11 FUSION PROTEIN; ONCOPROTEIN; PRIMER DNA;

ADOLESCENT; ADULT; BASE SEQUENCE; BONE MARROW TRANSPLANTATION; CHIMERA; CHROMOSOMES, HUMAN, PAIR 16; DNA PRIMERS; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; INVERSION, CHROMOSOME; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; ONCOGENE PROTEINS, FUSION; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; TIME FACTORS; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0031594385     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701056     Document Type: Article

References (26)

1. Le Beau MM, Larson RA, Bitter MA et al. Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia: a unique cytogenetic-clinical pathological association. New Engl J Med 1983; 309: 630-636.
2. Shurtleff SA, Meyers S, Hierbert SW et al. Heterogeneity in CBFβ/MYH11 fusion messages encoded by the inv(16)(p13q22) and the t(16;16)(p13;q22) in acute myelogenous leukemia. Blood 1995; 85: 3696-3703.
3. Okuda T, van Deursen J, Hiebert SW et al. AML1, the target of multiple chromosomal translocations in human leukemia, is essential for normal fetal liver hematopoiesis. Cell 1996; 84: 321-324.
4. Herbert J, Cayuela JM, Danie MT et al. Detection of minimal residual disease in acute myelomonocytic leukemia with abnormal marrow eosinophils by nested polymerase chain reaction with allele specific amplification. Blood 1994; 84: 2291-2296.
5. Claxton DF, Liu P, Hsu HB et al. Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 1994; 83: 1750-1756.
6. Poirel H, Radford-Weiss I, Rack K et al. Detection of the chromosome 16 CBFβ-MYH11 fusion transcript in myelomonocytic leukemias. Blood 1995; 85: 1313-1322.
7. Tobal K, Johnson PRE, Saunders MJ et al. Detection of CBFβ/MYH11 transcripts in patients with inversion 16 and other abnormalities of chromosome 16 at presentation and remission. Br J Haematol 1995; 91: 104-108.
8. Costello R, Sainty D, Blaise D et al. Prognosis value of residual disease monitoring by polymerase chain reaction in patients with CBF beta/MYH11-positive acute myeloblastic leukemia. Blood 1997; 89: 2222-2223 (letter).
9. Bennett JM, Catovsky D, Daniel MT et al. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British cooperative group. Ann Intern Med 1985; 103: 620-624.
10. Chomczynski P, Sacchi N. Single step method of RNA isolation by acid guanidium thiocyanate phenol chloroform extraction. Anal Biochem 1987; 162: 156-159.
11. Dveksler GS, Basile AA, Dieffenbach CW. Analysis of gene expression: use of oligonucleotide primers for glyceraldehyde-3-phosphate dehydrogenase. PCR Meth Appl 1992, pp 283-284.
12. Kwok S, Higuchi R. Avoiding false positives with PCR. Nature 1989; 339: 237-238.
13. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning. A Laboratory Manual. Cold Spring Harbor Laboratory Press: Cold Spring Harbor, NY, 1982.
14. Elmaagacli AH, Beelen DW et al. Molecular studies of chimerism and minimal residual disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation. Bone Marrow Transplant 1996; 18: 397-403.
15. Elmaagacli AH, Becks HW, Beelen DW et al. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia. Bone Marrow Transplant 1995; 16: 823-829.
16. Cui K-H, Warnes GM, Jeffrey R Colin DM. Sex determination of pre-implantation embryos by human testis-determining-gene amplification. Lancet 1994; 343: 79-82.
17. Evans PAS, Short MA, Jack AS et al. Detection and quantitation of the CBFβ/MYH11 transcripts associated with inv(16) in presentation and follow-up samples from patients with AML. Leukemia 1997; 11: 364-369.
18. Jurlander J, Caligiuri MA, Ruutu T et al. Persistence of the AML1/ETO fusion transcript in patients treated with allogeneic bone marrow transplantation for t(8;21) leukemia. Blood 1996; 88: 2183-2191.
19. Miyamoto T, Nagafuji K, Akashi K et al. Persistence of multipotent progenitors expressing AML1/ETO transcripts in long-term remission patients with t(8;21) acute myelogenous leukemia. Blood 1996; 87: 4789-4796.
20. Kusec R, Laczika K, Knobl P et al. AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 1994; 8: 735-739.
21. Downing JR, Head DR, Curcio-Brint AM et al. An AML1/ETO fusion transcript is consistently detected by RNA-based polymerase chain reaction in acute myelogenous leukemia containing the (8;21)(q22;q22) translocation. Blood 1993; 81: 2860-2865.
22. Saunders MJ, Tobal K, Yin JA. Detection of t(8;21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukaemia type M2 after chemotherapy or bone marrow transplantation. Leukemia Res 1994; 18: 891-895.
23. Nucifora G, Larson RA, Rowley JD. Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long-term remission. Blood 1993; 82: 712-715.
24. Guerrasio A, Rosso C, Martinelli G et al. Polyclonal haemopoiesis associated with long-term persistence of the AML1/ETO transcript in patients with FAB M2 acute myeloid leukemia in continous clinical remission. Br J Haematol 1995; 90: 364-373.
25. Wang S, Wang Q, Crute BE et al. Cloning and characterization of subunits of the T cell receptor and murine leukemia virus enhancer core-binding factor. EMBO J 1993; 13: 3324-3329.
26. Mackinnon S, Barnett L, Heller G, O'Reilly RJ. Minimal residual disease is more common in patients who have mixed T cell chimerism after bone marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 3409-3416.